Oleg Semenov

Oleg Semenov is a seasoned professional with a wealth of experience in strategic and operational management, medical affairs, clinical affairs, R&D, and consulting. He specializes in precision medicine, cell and gene therapy, immunotherapy, transplant medicine, and biobanking. Oleg's interests lie in digital transformation, new modality drugs, regenerative medicine, and 3D printing.

Oleg holds an impressive educational background, including a Master of Science with Distinction in Experimental Medicine from the Russian Academy of Medical Science (RAMS) and Saint Petersburg State Technological Institute (SPBSTI). He also pursued studies at prestigious institutions such as Harvard Medical School, MIT Sloan School of Management, The London School of Economics and Political Science (LSE), ETH-Zürich, and the University of Zurich.

Oleg Semenov has held key positions in renowned organizations, serving as Medical Alliances Operations Leader at Roche, Global Program Leader at Bayer, Senior Global Project Manager at Novartis, and various leadership roles at other prominent companies. His diverse experience includes roles in project management, consulting in regenerative medicine, and contributions to advancements in personalized medicine, stem cell therapy, immunotherapy, tissue engineering, and biobanking.